These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6018350)

  • 1. Treatment of ulcerative colitis with hydrocortisone alcohol retention enemas: a topical and systemic anti-inflammatory agent. II.
    Sherman LF; Tenner RJ; Schottler JL
    Dis Colon Rectum; 1967; 10(1):43-52. PubMed ID: 6018350
    [No Abstract]   [Full Text] [Related]  

  • 2. Roentgenographic reversibility of ulcerative colitis in children treated with steroid enemas.
    Goldberg HI; Carbone JV; Margulis AR
    Am J Roentgenol Radium Ther Nucl Med; 1968 Jun; 103(2):365-79. PubMed ID: 5656232
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of ulcerative colitis with hydrocortisone enemas. Comparison of absorption and clinical response with hydrocortisone alcohol and hydrocortisone acetate.
    Farmer RG; Schumacher OP
    Am J Gastroenterol; 1970 Sep; 54(3):229-36. PubMed ID: 5507287
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam.
    Ruddell WS; Dickinson RJ; Dixon MF; Axon AT
    Gut; 1980 Oct; 21(10):885-9. PubMed ID: 7002739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal biopsy in ulcerative colitis for evaluating topical hydrocortisone therapy.
    Kratzer GL; Panas PG; Onsanit T
    Dis Colon Rectum; 1973; 16(6):468-72. PubMed ID: 4149065
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas.
    Somerville KW; Langman MJ; Kane SP; MacGilchrist AJ; Watkinson G; Salmon P
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):866. PubMed ID: 3931745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of acute crisis of ulcerative colitis].
    Herrerias Gutiérrez JM; Pérez Ruilópez MA; Pellicer Bautista FJ; Garrido Peralta M
    Rev Esp Enferm Apar Dig; 1977 Jun; 50(5):541-8. PubMed ID: 887850
    [No Abstract]   [Full Text] [Related]  

  • 8. Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control. The Danish Budesonide Study Group.
    Scand J Gastroenterol; 1991 Dec; 26(12):1225-30. PubMed ID: 1763292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.
    Farthing MJ; Rutland MD; Clark ML
    Br Med J; 1979 Oct; 2(6194):822-4. PubMed ID: 509112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE TREATMENT OF ULCERATIVE COLITIS WITH HYDROCORTISONE ALCOHOL RETENTION ENEMAS.
    SHERMAN LF
    Minn Med; 1965 May; 48():605-10. PubMed ID: 14274418
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
    Rufle W; Frühmorgen P; Huber W; Kimmig JM
    Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sucralfate and hydrocortisone enemas in the treatment of active ulcerative proctitis--a randomized single-blind comparative study.
    Ardizzone S; Petrillo M; Antonacci CM; Bianchi Porro G
    Aliment Pharmacol Ther; 1996 Dec; 10(6):957-60. PubMed ID: 8971294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis.
    Nyman-Pantelidis M; Nilsson A; Wagner ZG; Borgå O
    Aliment Pharmacol Ther; 1994 Dec; 8(6):617-22. PubMed ID: 7696451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical corticosteroids in ulcerative colitis.
    Drug Ther Bull; 1975 Jan; 13(2):5-7. PubMed ID: 1212926
    [No Abstract]   [Full Text] [Related]  

  • 16. Enema volume as an important factor in successful topical corticosteroid treatment of colitis.
    Swarbrick ET; Loose H; Lennard-Jones JE
    Proc R Soc Med; 1974 Aug; 67(8):753-4. PubMed ID: 4417491
    [No Abstract]   [Full Text] [Related]  

  • 17. Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.
    Wright JP; Winter TA; Candy S; Marks IS
    Dig Dis Sci; 1999 Sep; 44(9):1899-901. PubMed ID: 10505732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapy is underused in patients with ulcerative colitis.
    Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
    J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.
    Hartmann F; Stein J;
    Aliment Pharmacol Ther; 2010 Aug; 32(3):368-76. PubMed ID: 20491741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of catarrhal and catarrho-erosive colitis with Repredsol (a new combination drug for topical application)].
    Sirakov P
    Vutr Boles; 1973; 12(4):92-7. PubMed ID: 4770082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.